Updates & Impacts: Treating Hematologic Malignancies in 2022 CME Information
After completing this activity, the participant should be better able to:
- Evaluate recent clinical treatment regimens that are being investigated in patients with indolent and aggressive forms of lymphoma
- Review current and emerging approaches to the treatment of patients with multiple myeloma, including novel combinations, BCMA-targeted therapies, cell signaling inhibitors, and chemotherapy formulations
- Debate recent data of therapies for patients with CLL, as well as how various patient- and disease-related factors impact selection and sequencing of agents
- Compare and contrast the safety and efficacy of novel approaches for the care of patients with acute leukemia, including acute myeloid leukemia and acute lymphoblastic leukemia
- Assess the clinical trial results of treatment strategies that are being investigated in patients with myeloproliferative neoplasms, including MF, PV, MDS, and other
Joint Accreditation Statement
Physician Continuing Medical Education
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
Planners and Managers
The PIM planners and managers have nothing to disclose. The Bio Ascend LLC planners and managers have nothing to disclose
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Request for Credit
In order to obtain your CME/CE certificate, please follow the steps below at the conclusion of the webinar:
- 1) Go to www.cmeuniversity.com
- 2) Login or Create a New Account (will take less than 1 minute)
- a) If you receive a message when creating a new account that “the email you entered is already in use”, please click the Forgot my Username or Password link to have your Username and Password sent to you via email
- b) After logging in, you may be asked to verify/update your information; after doing so, click Save at the bottom of the page
- 3) Type in 16925 at the top of the page, “Find Post-Test/Evaluation by Course”, and click enter
- 4) Click on the activity title when it appears
- 5) Choose the type of credit you desire
- 6) Complete the online Evaluation
- 7) Receive an immediate CME/CE Certificate to download and/or print for your files
If you have questions regarding the certification of this activity, please contact PIM via email at email@example.com.